204 related articles for article (PubMed ID: 26880370)
21. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia.
Tamiya S; Matsuoka M; Etoh K; Watanabe T; Kamihira S; Yamaguchi K; Takatsuki K
Blood; 1996 Oct; 88(8):3065-73. PubMed ID: 8874205
[TBL] [Abstract][Full Text] [Related]
22. [Significance of TET2 mutations in myeloid and lymphoid neoplasms].
Chiba S
Rinsho Ketsueki; 2016 Jun; 57(6):715-22. PubMed ID: 27384850
[TBL] [Abstract][Full Text] [Related]
23. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia.
Furukawa Y; Kubota R; Tara M; Izumo S; Osame M
Blood; 2001 Feb; 97(4):987-93. PubMed ID: 11159527
[TBL] [Abstract][Full Text] [Related]
24. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
[TBL] [Abstract][Full Text] [Related]
25. Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia.
Yamazaki J; Taby R; Vasanthakumar A; Macrae T; Ostler KR; Shen L; Kantarjian HM; Estecio MR; Jelinek J; Godley LA; Issa JP
Epigenetics; 2012 Feb; 7(2):201-7. PubMed ID: 22395470
[TBL] [Abstract][Full Text] [Related]
26. Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene.
Watanabe T; Yamaguchi K; Takatsuki K; Osame M; Yoshida M
J Exp Med; 1990 Sep; 172(3):759-65. PubMed ID: 2388034
[TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells.
Yamato K; Oka T; Hiroi M; Iwahara Y; Sugito S; Tsuchida N; Miyoshi I
Jpn J Cancer Res; 1993 Jan; 84(1):4-8. PubMed ID: 8449826
[TBL] [Abstract][Full Text] [Related]
28. TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns.
Damm F; Markus B; Thol F; Morgan M; Göhring G; Schlegelberger B; Krauter J; Heuser M; Bernard OA; Ganser A
Genes Chromosomes Cancer; 2014 Oct; 53(10):824-32. PubMed ID: 24898826
[TBL] [Abstract][Full Text] [Related]
29. Potential immunogenicity of adult T cell leukemia cells in vivo.
Kurihara K; Harashima N; Hanabuchi S; Masuda M; Utsunomiya A; Tanosaki R; Tomonaga M; Ohashi T; Hasegawa A; Masuda T; Okamura J; Tanaka Y; Kannagi M
Int J Cancer; 2005 Mar; 114(2):257-67. PubMed ID: 15551352
[TBL] [Abstract][Full Text] [Related]
30. Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation.
Yuen CK; Chan CP; Fung SY; Wang PH; Wong WM; Tang HV; Yuen KS; Chan CP; Jin DY; Kok KH
J Virol; 2016 Apr; 90(8):3902-3912. PubMed ID: 26819312
[TBL] [Abstract][Full Text] [Related]
31. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms.
Taniguchi Y; Nosaka K; Yasunaga J; Maeda M; Mueller N; Okayama A; Matsuoka M
Retrovirology; 2005 Oct; 2():64. PubMed ID: 16242045
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic alterations in hematopoietic malignancies.
Chung YR; Schatoff E; Abdel-Wahab O
Int J Hematol; 2012 Oct; 96(4):413-27. PubMed ID: 23015417
[TBL] [Abstract][Full Text] [Related]
33. Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100.
Watanabe T; Yamashita S; Ureshino H; Kamachi K; Kurahashi Y; Fukuda-Kurahashi Y; Yoshida N; Hattori N; Nakamura H; Sato A; Kawaguchi A; Sueoka-Aragane N; Kojima K; Okada S; Ushijima T; Kimura S; Sueoka E
Blood; 2020 Aug; 136(7):871-884. PubMed ID: 32391874
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia.
Cull AH; Mahendru D; Snetsinger B; Good D; Tyryshkin K; Chesney A; Ghorab Z; Reis M; Buckstein R; Wells RA; Rauh MJ
Leuk Res; 2018 Feb; 65():5-13. PubMed ID: 29227812
[TBL] [Abstract][Full Text] [Related]
35. Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation.
El-Sabban ME; Nasr R; Dbaibo G; Hermine O; Abboushi N; Quignon F; Ameisen JC; Bex F; de Thé H; Bazarbachi A
Blood; 2000 Oct; 96(8):2849-55. PubMed ID: 11023521
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.
Cheng J; Zhang D; Zhou C; Marasco WA
Leuk Res; 2004 Jan; 28(1):71-82. PubMed ID: 14630083
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of c-Myb Pathway by Aberrant Expression of Proto-oncogene MYB Provides the Basis for Malignancy in Adult T-cell Leukemia/lymphoma Cells.
Nakano K; Uchimaru K; Utsunomiya A; Yamaguchi K; Watanabe T
Clin Cancer Res; 2016 Dec; 22(23):5915-5928. PubMed ID: 27307595
[TBL] [Abstract][Full Text] [Related]
38. Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells.
Mori N; Fujii M; Iwai K; Ikeda S; Yamasaki Y; Hata T; Yamada Y; Tanaka Y; Tomonaga M; Yamamoto N
Blood; 2000 Jun; 95(12):3915-21. PubMed ID: 10845928
[TBL] [Abstract][Full Text] [Related]
39. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.
Cesarman E; Chadburn A; Inghirami G; Gaidano G; Knowles DM
Blood; 1992 Dec; 80(12):3205-16. PubMed ID: 1361372
[TBL] [Abstract][Full Text] [Related]
40. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma.
Ohshima K; Haraoka S; Yoshioka S; Hamasaki M; Fujiki T; Suzumiya J; Kawasaki C; Kanda M; Kikuchi M
Cancer Lett; 2000 Oct; 158(2):141-50. PubMed ID: 10960763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]